SI9500121A - Intranasal antimigraine composition - Google Patents

Intranasal antimigraine composition Download PDF

Info

Publication number
SI9500121A
SI9500121A SI9500121A SI9500121A SI9500121A SI 9500121 A SI9500121 A SI 9500121A SI 9500121 A SI9500121 A SI 9500121A SI 9500121 A SI9500121 A SI 9500121A SI 9500121 A SI9500121 A SI 9500121A
Authority
SI
Slovenia
Prior art keywords
composition
cytosan
composition according
pharmaceutically acceptable
acid addition
Prior art date
Application number
SI9500121A
Other languages
English (en)
Slovenian (sl)
Inventor
Marc Karel Jozef Francois
Roger Carolus August Embrechts
Lisbeth Illum
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SI9500121A publication Critical patent/SI9500121A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI9500121A 1994-04-13 1995-04-12 Intranasal antimigraine composition SI9500121A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94200998 1994-04-13

Publications (1)

Publication Number Publication Date
SI9500121A true SI9500121A (en) 1995-10-31

Family

ID=8216793

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9500121A SI9500121A (en) 1994-04-13 1995-04-12 Intranasal antimigraine composition

Country Status (23)

Country Link
EP (1) EP0755253B1 (xx)
JP (1) JP2921988B2 (xx)
KR (1) KR100219952B1 (xx)
CN (1) CN1146151A (xx)
AT (1) ATE194915T1 (xx)
AU (1) AU684360B2 (xx)
BG (1) BG62197B1 (xx)
BR (1) BR9507369A (xx)
CA (1) CA2184822C (xx)
CZ (1) CZ286610B6 (xx)
DE (1) DE69518149T2 (xx)
FI (1) FI118295B (xx)
HR (1) HRP950149A2 (xx)
HU (1) HU219495B (xx)
IL (1) IL113341A (xx)
NO (1) NO310276B1 (xx)
NZ (1) NZ284454A (xx)
PL (1) PL179761B1 (xx)
RO (1) RO115414B1 (xx)
SI (1) SI9500121A (xx)
SK (1) SK129896A3 (xx)
WO (1) WO1995028158A1 (xx)
ZA (1) ZA953038B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970032844A (ko) * 1995-12-29 1997-07-22 김준웅 지속성 경비투여제제
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0328186D0 (en) 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
JPH0656675A (ja) * 1992-08-07 1994-03-01 Nippon Soda Co Ltd 家畜の乳房炎予防剤

Also Published As

Publication number Publication date
NZ284454A (en) 1997-12-19
HRP950149A2 (en) 1997-06-30
EP0755253A1 (en) 1997-01-29
DE69518149T2 (de) 2001-03-22
NO964333D0 (no) 1996-10-11
SK129896A3 (en) 1997-05-07
ATE194915T1 (de) 2000-08-15
BR9507369A (pt) 1997-09-23
CA2184822C (en) 2000-12-19
FI964095A (fi) 1996-10-11
CZ292096A3 (en) 1997-02-12
DE69518149D1 (de) 2000-08-31
FI118295B (fi) 2007-09-28
HU9602806D0 (en) 1996-11-28
IL113341A (en) 2000-08-31
JP2921988B2 (ja) 1999-07-19
AU2305495A (en) 1995-11-10
WO1995028158A1 (en) 1995-10-26
BG100889A (en) 1997-07-31
HU219495B (hu) 2001-04-28
ZA953038B (en) 1996-10-14
KR100219952B1 (ko) 1999-09-01
BG62197B1 (bg) 1999-05-31
CN1146151A (zh) 1997-03-26
IL113341A0 (en) 1995-07-31
NO964333L (no) 1996-10-11
HUT75939A (en) 1997-05-28
AU684360B2 (en) 1997-12-11
EP0755253B1 (en) 2000-07-26
CZ286610B6 (cs) 2000-05-17
PL316756A1 (en) 1997-02-03
JPH09505606A (ja) 1997-06-03
RO115414B1 (ro) 2000-02-28
CA2184822A1 (en) 1995-10-26
FI964095A0 (fi) 1996-10-11
PL179761B1 (pl) 2000-10-31
NO310276B1 (no) 2001-06-18

Similar Documents

Publication Publication Date Title
JP3278192B2 (ja) 徐放性液剤
US20040138237A1 (en) Novel injectable depot formulations
SK97299A3 (en) The use of a pharmaceutical composition for oral administration
US7175856B2 (en) Palatable oral suspension and method
JP2003501468A (ja) アポモルヒネの経鼻送達
JP2005506992A (ja) 薬理学的に活性な化合物の制御送達のための注射用組成物
JP6818019B2 (ja) レファムリンの注射可能医薬組成物
JP2002356424A (ja) １，２，３，９−テトラヒドロ−９−メチル−３−［（２−メチル−１ｈ−イミダゾール−１−イル）メチル］−４ｈ−カーバゾール−４−オンを有效成分とする鼻腔噴霧用組成物
EP1237538A2 (en) An improved pharmaceutical composition for treating male erectile dysfunction
EP3013316B1 (en) Stable intravenous formulation
SI9500121A (en) Intranasal antimigraine composition
US6054462A (en) Intranasal antimigraine compositions
AU2003287476B2 (en) Improved formulations containing substituted imidazole derivatives
WO2001056610A1 (en) Stabilised pharmaceutical compositions and process for their preparation comprising an antibiotic and an expectorant
US5084276A (en) Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation
KR20230002361A (ko) 카파 오피오이드 수용체 효능제의 올리고당 제형
CZ247299A3 (cs) Použití farmaceutické směsi pro ústní podání

Legal Events

Date Code Title Description
IF Valid on the event date